Application 208554
- Type
- ANDA
- Sponsor
- BAXTER HLTHCARE CORP
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | EPTIFIBATIDE | EPTIFIBATIDE | INJECTABLE;INJECTION | 2MG/ML | No | No |
| 002 | EPTIFIBATIDE | EPTIFIBATIDE | INJECTABLE;INJECTION | 75MG/100ML | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0338-9558 | Eptifibatide | Eptifibatide | Baxter Healthcare Corporation | ANDA | Current |
| 0338-9558 | Eptifibatide | Eptifibatide | Baxter Healthcare Corporation | ANDA | Current |
| 0338-9558 | Eptifibatide | Eptifibatide | Baxter Healthcare Corporation | ANDA | Current |
| 0338-9558 | Eptifibatide | Eptifibatide | Baxter Healthcare Corporation | ANDA | Current |
| 0338-9558 | Eptifibatide | Eptifibatide | Baxter Healthcare Corporation | ANDA | Current |
| 0338-9558 | Eptifibatide | Eptifibatide | Baxter Healthcare Corporation | ANDA | Current |
| 0338-9558 | Eptifibatide | Eptifibatide | Baxter Healthcare Corporation | ANDA | Current |
| 0338-9559 | Eptifibatide | Eptifibatide | Baxter Healthcare Corporation | ANDA | Current |
| 0338-9559 | Eptifibatide | Eptifibatide | Baxter Healthcare Corporation | ANDA | Current |
| 0338-9559 | Eptifibatide | Eptifibatide | Baxter Healthcare Corporation | ANDA | Current |
| 0338-9559 | Eptifibatide | Eptifibatide | Baxter Healthcare Corporation | ANDA | Current |
| 0338-9559 | Eptifibatide | Eptifibatide | Baxter Healthcare Corporation | ANDA | Current |